Citigroup’s China Pharma Holdings CPHI Stock Holding History

Citigroup’s Portfolio CPHI Stock Details CPHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$608	Buy	+996	New	+$837	﹤0.01%	5523
2025 Q1	–	Sell	-533	Closed	-$1.24K	–	5657
2024 Q4	$1.24K	Buy	+533	New	+$1.15K	﹤0.01%	5581
2015 Q2	–	Sell	-3	Closed	-$1K	–	7549
2015 Q1	$1K	Buy	+3	New	+$518	﹤0.01%	7034

Other funds holding CPHI

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

EFG International Zurich $4.67B AUM

Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Citigroup's CPHI Position: Q1 2026 in Review

Citigroup opened a new position in China Pharma Holdings (CPHI) in Q1 2026: 996 shares worth $608. The stake represents ﹤0.01% of the portfolio and ranks #5523 among its holdings. This is a return to the name: Citigroup previously reported a position in CPHI as recently as Q4 2024.

Citigroup first reported a position in CPHI in Q1 2015 and has held it in 3 quarters since. The position peaked at $1.24K in Q4 2024. 6 funds tracked by Wall St. Rank hold CPHI as of Q1 2026.

Citigroup held 996 shares of China Pharma Holdings worth $608 as of Q1 2026.
China Pharma Holdings was a new Citigroup position in Q1 2026.
China Pharma Holdings made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5523 holding.
Citigroup first reported a position in China Pharma Holdings in Q1 2015 and has held it in 3 quarters since.
Citigroup's China Pharma Holdings position peaked at $1.24K in Q4 2024.
6 funds tracked by Wall St. Rank held China Pharma Holdings as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.